Prevalence of Trismus in Patients With Maxillary Cancer With and Without Radiation Therapy in the Egyptian Population.

: Post-operative Prevalence of Trismus in Patients With Maxillary Cancer With and Without Radiation Therapy in the Egyptian Population.(a Cross Sectional Study)

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05091814

Enrollment

360

Registered

2021-10-25

Start date

2021-12-31

Completion date

2022-12-31

Last updated

2021-10-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Maxillary Neoplasms

Keywords

surgery , Trismus, Oral

Brief summary

This study aims at evaluating the prevalence of trismus among maxillary cancer patients in the Egyptian population and the effect of radiotherapy on the occurrence of trismus.

Detailed description

The enrolled participants who meet the eligibility criteria and signed the informed consent of participation in the study will undergo clinical examination to determine the maximum mouth opening after performing surgery only and /or after radiotherapy in case of adjuvant therapy the maximum mouth opening will be measured in (mm) by using a digital caliper device and will be recorded in the patient sheet, reading of less than 35mm will be considered trismus while above 35mm or more will be considered normal (NO trismus)

Interventions

RADIATIONradiotherapy

patients who recieved radiotherapy after surgical removal of the tumor

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* patients with maxillary cancer

Exclusion criteria

* patients under 18 yrs . * patients with TMJ disorders before surgery * patients on chemotherapy * \- Tumors in other sites( Tongue , buccal mucosa , salivary glands, mandible)

Design outcomes

Primary

Measure	Time frame	Description
% prevalence	1 year	Trismus prevalence in percent

Secondary

Measure	Time frame	Description
MMO	1 year	maximum mouth opening

Countries

Egypt

Contacts

Primary ContactErfan

mohamed.diaa@dentistry.cu.edu.eg01111594776

Backup ContactKhashab

mohamed.elkhashab@dentistry.cu.edu.eg01006611525

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026